Nov 5 (Reuters) - SIEMENS HEALTHINEERS AG SHLG.DE:
Q4 REVENUE AT 6.322 BILLION EUROS VERSUS EXPECTED 6.451 BILLION EURO
Q4 COMPARABLE REVENUE GROWTH RATE AT 3.7% VERSUS EXPECTED 4.8%
FY COMPARABLE REVENUE GROWTH RATE AT 5.9% VERSUS EXPECTED 6.3%
Q4 ADJUSTED EBIT AT 1.098 BILLION EURO VERSUS EXPECTED 1.128 BILLION EURO
FY FREE CASH FLOW AT 2.7 BILLION EURO VERSUS 2.504 BILLION EURO EXPECTED
Q4 NET INCOME AT 597 MILLION EURO (Q4 2024: 624 MILLION EURO)
FY 2025 PROPOSED DIVIDEND OF 1 EURO PER SHARE (FY 2024: 0.95 EUROS PER SHARE)
OUTLOOK FY 2026: EXPECT COMPARABLE REVENUE GROWTH OF BETWEEN 5% TO 6% COMPARED WITH FY 2025
OUTLOOK FY 2026: EXPECT ADJUSTED BASIC EARNINGS PER SHARE BETWEEN 2.20 EUROS AND 2.40 EUROS
TARIFFS IN FY 2024/ 25 WILL COST AROUND 200 MILLION EUROS, IN 2025/26 AROUND 400 MILLION EUROS
Further company coverage: SHLG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))